Aurora Spine Grants Stock Options
Carlsbad, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB:ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announces that it has granted options (the “Options”) to acquire 1,000,000 common shares of the Company to Trent J. Northcutt, President & CEO. The Options are exercisable at a price of CDN$0.395 per common share and vest one third on the first, second and third annual anniversaries from the date of grant. The Options have a term of five years and are subject in all respects to the terms of the Company’s stock option plan.
Related news for (ASAPF)
- Aurora Spine Announces Initial Surgeries using its AERO™ Lumbar Fusion System
- Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
- Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
- Aurora Spine Corporation Announces Record First Quarter Financial Results
- Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results